COCP logo

COCPCocrystal Pharma Inc

$0.9643
$0.0857
(8.16%)
Today
Closed $0.9643
$0.0197
(2.04%)
After Hours
Updated: 07:58 PM EDT
Reported EarningsMay 15
Mkt Cap$14.48M
Vol160,197.00
News
all
press releases
Cocrystal Pharma Names James Sapirstein CEO, Stock Up In Pre-market
(RTTNews) - Cocrystal Pharma, Inc. (COCP) on Wednesday announced that it has appointed James Sapirstein chief executive officer, effective immediately, replacing co-chief executives Sam Lee and Jim Martin...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
Why Cocrystal Pharma Shares Are Cooling Off Monday?
COCP stock is trading lower Monday morning. Learn why Cocrystal Pharma is seeing a pullback after receiving FDA Fast Track designation for CDI-988.read more...
Benzinga
News Placeholder
Top Biotech Stocks To Follow Today - April 4th
Vertex Pharmaceuticals, Danaher, United Therapeutics, argenex, Moderna, Cocrystal Pharma, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat
News Placeholder
Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results
US stocks fall, Dow drops over 50 points, real estate shares rise, Acuity Inc. shares decline, Sky Quarry Inc. and Cocrystal Pharma Inc. shares increase.read more...
Benzinga
News Placeholder
Energy Crunch Sparks Sector Rally and Hidden Players Stepping into the Spotlight
A powerful convergence of global energy disruption and emerging technology catalysts is reshaping pockets of the market, with select small-cap names ready to make moves. $SKYQ, $XERI, $KBLB, $TGNT, $BDRX, $COCP
24-7 Market News
News Placeholder
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988
Cocrystal Pharma Inc. (NASDAQ:COCP) shares are trading higher Thursday after it received Fast Track designation from the FDA for its CDI-988.read more...
Benzinga
News Placeholder
COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment?
Cocrystal stated that the Fast Track designation for CDI-988 enables accelerated development and expedited regulatory review.
Stocktwits
News Placeholder
Cocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost Acquires 50,000 Shares
Cocrystal Pharma, Inc. (NASDAQ:COCP - Get Free Report) Director Phillip Md Et Al Frost purchased 50,000 shares of Cocrystal Pharma stock in a transaction that occurred on Friday, February 6th. The...
MarketBeat
News Placeholder
Phillip Md Et Al Frost Acquires 50,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock
Cocrystal Pharma, Inc. (NASDAQ:COCP - Get Free Report) Director Phillip Md Et Al Frost bought 50,000 shares of the company's stock in a transaction on Wednesday, December 31st. The shares were...
MarketBeat
News Placeholder
Cocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost Buys 20,000 Shares
Cocrystal Pharma, Inc. (NASDAQ:COCP - Get Free Report) Director Phillip Md Et Al Frost bought 20,000 shares of the firm's stock in a transaction dated Tuesday, December 30th. The stock was acquired...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.